“LEQEMBI” (Lecanemab) Approved for the Treatment of Alzheimer’s Disease in the United Arab Emirates

TOKYO and CAMBRIDGE, Mass., Aug 14, 2024 – (JCN Newswire via SeaPRwire.com) – Eisai Co., Ltd. and Biogen Inc. announced today that the Ministry of Health and Prevention in the United Arab Emirates (UAE) has approved humanized anti-soluble aggregated amyloid-beta (Aβ) monoclonal antibody “LEQEMBI®” (lecanemab) for the treatment of Alzheimer’s disease (AD). Treatment with LEQEMBI […]

Sino Biopharmaceutical (1177.HK) Announces 2024 Interim Results

Development Highlights – During the reporting Period, four of the Group’s innovative products were approved for marketing by the National Medical Products Administration of China (“NMPA”), namely Andewei (Benmelstobart Injection), Anboni (Unecritinib capsules), Anluoqing (Envonalkib capsules) and Beilelin (Liraglutide Injection), three of which are national category 1 innovative drugs. – In the first half of […]

UN Official: Houthis Seize Human Rights Office in Sanaa

The Houthi rebels in Yemen stormed the headquarters of the United Nations’ Human Rights Office in the capital, Sanaa, seizing documents, furniture, and vehicles, a senior U.N. official said Tuesday. This seizure is the latest escalation in the Houthis’ crackdown on individuals working with the U.N., aid agencies, and foreign embassies. The crackdown coincides with […]